Table 7.
Outlier breakdown by optimization type and similarity type.
| Lower-bound (< μ[μ(XT)] - σ[μ(XT)]) | Upper-bound (> μ[μ(XT)] + σ[μ(XT)]) | |||||
|---|---|---|---|---|---|---|
| ST | CT | ComboT | ST | CT | ComboT | |
| ST-optimization | ||||||
| screening | 10 (2.3%) | 7 (1.6%) | 7 (1.6%) | 32 (7.2%) | 11 (2.5%) | 23 (5.2%) |
| confirmatory | 69 (9.3%) | 8 (1.1%) | 19 (2.6%) | 85 (11.5%) | 63 (8.5%) | 75 (10.1%) |
| summary | 1 (11.1%) | 0 (0.0%) | 0 (0.0%) | 2 (22.2%) | 3 (33.3%) | 2 (22.2%) |
| other | 4 (4.1%) | 1 (1.0%) | 3 (3.1%) | 19 (19.6%) | 17 (17.5%) | 19 (19.6%) |
| unspecified | 18 (18.6%) | 0 (0.0%) | 9 (9.3%) | 4 (4.1%) | 1 (1.0%) | 1 (1.0%) |
| All | 102 (7.3%) | 16 (1.2%) | 38 (2.7%) | 142 (10.2%) | 95 (6.8%) | 120 (8.6%) |
| CT-optimization | ||||||
| screening | 10 (2.3%) | 8 (1.8%) | 9 (2.0%) | 31 (7.0%) | 13 (2.9%) | 23 (5.2%) |
| confirmatory | 70 (9.4%) | 12 (1.6%) | 22 (3.0%) | 81 (10.9%) | 66 (8.9%) | 76 (10.2%) |
| summary | 2 (22.2%) | 0 (0.0%) | 1 (11.1%) | 2 (22.2%) | 3 (33.3%) | 3 (33.3%) |
| other | 3 (3.1%) | 2 (2.1%) | 2 (2.1%) | 22 (22.7%) | 18 (18.6%) | 21 (21.6%) |
| unspecified | 19 (19.6%) | 0 (0.0%) | 5 (5.2%) | 3 (3.1%) | 1 (1.0%) | 2 (2.1%) |
| All | 104 (7.5%) | 22 (1.6%) | 39 (2.8%) | 139 (10.0%) | 101 (7.3%) | 125 (9.0%) |
The count of assay outliers that have a significant similarity score difference between the NN and NI pairs. Numbers in parentheses are the percentages of outliers relative to the assay-type counts shown in Figure 8(c).